重组人促甲状腺激素加重分化型甲状腺癌全甲状腺切除术后患者的肾皮质灌注和肾功能损害
研究纳入24例因分化型甲状腺癌行全甲状腺切除术、仅接受左甲状腺素治疗并符合放射性碘治疗条件的患者,连续两天给予重组人促甲状腺激素后行放射性碘治疗。结果显示第二次给药后肾灌注显著恶化,随后肾小球滤过率显著下降,而血流动力学参数无显著影响,提示促甲状腺激素可不依赖甲状腺激素浓度影响肾灌注和肾功能。
要点
- 全甲状腺切除术后分化型甲状腺癌患者给予重组人促甲状腺激素后肾灌注显著恶化。
- 第二次重组人促甲状腺激素给药后肾小球滤过率显著下降。
- 重组人促甲状腺激素未显著影响可能恶化肾功能的血流动力学参数。
核心结论
- 本研究表明促甲状腺激素本身、不依赖甲状腺激素浓度,可影响肾灌注和肾功能。
研究设计与样本
- 研究纳入24例因分化型甲状腺癌行全甲状腺切除术、无合并症、仅接受左甲状腺素治疗并符合放射性碘治疗条件的患者。
- 患者连续两天接受重组人促甲状腺激素,随后行放射性碘治疗。
- 在第二次重组人促甲状腺激素剂量前和24小时后及放射性碘治疗前进行甲状腺和肾功能临床与生化评估,住院第六天重新评估肾小球滤过率。
- 在第二次重组人促甲状腺激素剂量前和24小时后及放射性碘治疗前使用彩色多普勒超声评估肾灌注。
主要发现
- 在放射性碘治疗前第二次重组人促甲状腺激素剂量后,患者肾灌注出现显著恶化,随后肾小球滤过率显著降低。
- 重组人促甲状腺激素未显著影响可能恶化肾功能的血流动力学参数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Although thyrotropin (TSH) receptors are found in many nonthyroid tissues, we know little about the direct action of TSH on these receptors. Patients after total thyroidectomy for differentiated thyroid cancer (DTC) provide an interesting model for studying this issue. The administration of exogenous TSH in patients with an established thyroid state on levothyroxine (LT4) treatment allows us to study the effect of elevated TSH concentrations independent of thyroid status on the function of various organs, including the kidneys. The aim of this study was to assess the effects of the administration of recombinant human TSH (rhTSH) on renal perfusion and glomerular filtration in this group of patients. Methods: The study included 24 patients after total thyroidectomy due to DTC, without concomitant diseases, receiving only LT4 who qualified for radioiodine treatment (RIT). For two consecutive days, the patients received rhTSH and subsequently the RIT. Clinical and biochemical evaluation of thyroid and renal function was carried out before and 24 hours after the second dose of rhTSH and before the RIT. On the sixth day of hospitalization, the patients' glomerular filtration rate was re-evaluated. Kidney perfusion was assessed using color Doppler ultrasound imaging before and 24 hours after the second dose of rhTSH and before the RIT. Results: The administration of rhTSH to patients after total thyroidectomy due to DTC caused significant deterioration of renal perfusion after the second dose of rhTSH before the RIT, which was followed by a significant reduction in glomerular filtration. Furthermore, rhTSH did not significantly affect the hemodynamic parameters that could worsen renal function. Conclusions: This study indicates that TSH alone, independent of thyroid hormone concentrations, can influence renal perfusion and renal function.
引用
- Saracyn M, Lubas A, Bober B, et al. Recombinant Human Thyrotropin Worsens Renal Cortical Perfusion and Renal Function in Patients After Total Thyroidectomy Due to Differentiated Thyroid Cancer. Thyroid. 2020. PMID: 31964314. doi:10.1089/thy.2019.0372
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。